Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Do Heart Attacks Really Strike Without Warning, or Are We Just Missing Signs? Study Sheds Light Cardiology and CTVS

Do Heart Attacks Really Strike Without Warning, or Are We Just Missing Signs? Study Sheds Light

  • 01 October 2025
  • 1 month ago

HF therapy guided by wearable devices effective in reducing mortality: Study Cardiology and CTVS

HF therapy guided by wearable devices effective in reducing mortality: Study

  • 30 September 2025
  • 1 month ago

Pneumococcal Disease Risk and Vaccination in Cardiac Conditions: Indian Cardiologists' Group Recommendations ENT

Pneumococcal Disease Risk and Vaccination in Cardiac Conditions: Indian Cardiologists' Group Recommendations

  • 29 September 2025
  • 1 month ago

Risk-Guided Screening Spots Early Heart Damage in Cancer Survivors: REDEEM Trial Medicine

Risk-Guided Screening Spots Early Heart Damage in Cancer Survivors: REDEEM Trial

  • 24 September 2025
  • 1 month ago

FDA Approves Bumetanide Nasal Spray for Edema in Heart, Liver, and Kidney Disease Gastroenterology

FDA Approves Bumetanide Nasal Spray for Edema in Heart, Liver, and Kidney Disease

  • 18 September 2025
  • 1 month ago

Digitoxin Reduces Mortality and Hospitalizations in Heart Failure with Reduced Ejection Fraction: NEJM Medicine

Digitoxin Reduces Mortality and Hospitalizations in Heart Failure with Reduced Ejection Fraction: NEJM

  • 17 September 2025
  • 1 month ago

Pregabalin Linked to Higher Heart Failure Risk Compared to Gabapentin: JAMA Cardiology and CTVS

Pregabalin Linked to Higher Heart Failure Risk Compared to Gabapentin: JAMA

  • 09 September 2025
  • 1 month ago

Glyceraldehyde Derivatives Inspired By Empagliflozin Potential Anti-Heart Failure Agents Independent Of Glucose-Lowering Effects: Study Diabetes and Endocrinology

Glyceraldehyde Derivatives Inspired By Empagliflozin Potential Anti-Heart Failure Agents Independent Of Glucose-Lowering Effects: Study

  • 22 July 2025
  • 3 months ago

Recent News

Study Reveals Citrus and Grape Compounds May Help...

  • 04 November, 2025

What Your Neck Size Says About Your Heart Health?...

  • 04 November, 2025

EVOQUE TTVR Delivers Promising Real-World Results:...

  • 04 November, 2025

Influenza Vaccination Reduces Mortality and Readmi...

  • 04 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.